Search Results 1301-1310 of 17865 for monoclonal antibody

1. Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors - Mayo Clinic

   Monoclonal antibodies =< 3 half-lives prior to registration; Radiation therapy. Last fraction of craniospinal irradiation or total body irradiation =< 3 ...

2. A Study of JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/​r B-NHL) - Mayo Clinic

   Participants also must have prior exposure to an anti-CD20 monoclonal antibody. Tumor must be cluster of differentiation (CD) 20 positive; Measurable disease ...

3. A Study of Cell, Serum, and Bone Marrow Bank for Patients receiving Chimeric Antigen Receptor T Cell Therapy for the Treatment of Cancer - Mayo Clinic

   ... antibodies and the factors that may determine disease progression and treatment response. ... Plan to initiate treatment with either bi-specific antibody or CAR-T ...

4. A Study to Determine the Effectiveness and Safety of Benralizumab for Patients with Severe Nasal Polyposis - Mayo Clinic

   Receipt of any marketed or investigational biologic products (monoclonal or polyclonal antibody) ... This also applies to patients who previously participated in ...

5. Tuberculosis - Diagnosis & treatment - Mayo Clinic

   This test is seeing if your immune system reacts, or has made an antibody, to tuberculosis. A positive test indicates you likely have either a latent TB ...

6. A Study To Evaluate Tazemetostat Combined With Lenalidomide Plus Rituximab In Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

   Monoclonal antibody(ies) - at least 28 days;. Radiotherapy - at least 6 weeks from prior radioisotope therapy; at least 12 weeks from 50% pelvic or total ...

7. At-home colon cancer tests - Mayo Clinic

   A fecal immunochemical test (FIT) uses antibodies to find tiny amounts of hemoglobin in your stool. ... Monoclonal antibody medicines for cancer: How they work.

8. A Study to Evaluate the Effectiveness and Safety of Cobomarsen (MRG-106) vs. Active Comparator in Subjects with Mycosis Fungoides - Mayo Clinic

   Antibody-directed or immunoglobulin-based immune therapy or other monoclonal antibody therapies within 8 weeks prior to Screening;; Previous chronic (more ...

9. A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Prior use of lenalidomide, or monoclonal antibodies against CTLA-4, PD-1, or PD-L1. High risk of developing thromboembolic events, who are unwilling to take ...

10. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

    ... monoclonal antibody, if eligible for this therapy;. Anti-EGFR (epidermal growth factor receptor) monoclonal antibody, if eligible for this therapy.